echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Sales of 5 star drugs have soared!

    Sales of 5 star drugs have soared!

    • Last Update: 2021-06-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, national leaders proposed to "further develop traditional Chinese medicine.


    100 billion retail Chinese patent medicine market, with respiratory disease drugs taking the lead

    100 billion retail Chinese patent medicine market, with respiratory disease drugs taking the lead

    In recent years, under the promotion of medical reform, capital and Internet technology, the pharmaceutical retail industry has continuously undergone new changes in its industry development and business model


    Sales of proprietary Chinese medicines in physical pharmacies in cities in China (unit: 100 million yuan)

    Source: Mi Nei.


    Among the 13 treatment categories of proprietary Chinese medicines, medicines for respiratory diseases ranked first with a market share of 26.


    2020 China's urban physical pharmacies terminal TCM major category pattern

    Source: Mi Nei.


    Among the top 20 proprietary Chinese medicine manufacturers, Donge Ejiao, China Resources Sanjiu Pharmaceutical, Taiji Group Chongqing Fuling Pharmaceutical, and Yunnan Baiyao Group have sales of more than 2 billion yuan


    The market pattern of TOP20 proprietary Chinese medicine manufacturers in China's urban physical pharmacies in 2020

    Source: Mi Nei.


    TOP20 proprietary Chinese medicines are released! 5 star product markets soared

    TOP20 proprietary Chinese medicines are released! 5 star product markets soared

    2020 China's urban entity pharmacy terminal TCM products TOP20

    Source: Mi Nei.


    Among the TOP20 proprietary Chinese medicine products, 11 products have sales of more than 1 billion yuan, with donkey-hide gelatin, Angong Niuhuang pills, and Ganmaoling granules ranking the top three, with sales exceeding 2 billion yuan


    Sales of five star products have soared, including Lianhua Qingwen Capsules, Banlangen Granules, Shuanghuanglian Oral Liquid, Pien Tze Huang and Antiviral Oral Liquid


    Both Shuanghuanglian Oral Liquid and Banlangen Granules were sold out overnight due to the epidemic.


    Pien Tze Huang is an exclusive product of Zhangzhou Pien Tze Huang Pharmaceutical.


    Anti-viral oral liquid is used for wind-heat cold, febrile fever, upper respiratory tract infection, influenza, mumps virus infection and other diseases


    China Resources, Tai Chi, Yangtze River.


    China Resources, Tai Chi, Yangtze River.


    Source: Mi Nei.


    Among the TOP20 proprietary Chinese medicine brands, 10 brands have sales of more than 1 billion yuan.
    Dong-E-E-Jiao's donkey-hide gelatin is still the leading product in the traditional Chinese patent medicine market of physical pharmacies.
    Yiling Pharmaceutical's Lianhua Qingwen Capsules and Yangzijiang Pharmaceutical Group's Lanqin Oral liquid has entered the billion-dollar echelon for the first time
    .

    A total of 4 brands of China Resources Pharmaceutical's companies are on the list, and Baiyunshan has 2 brands on the list
    .
    From the perspective of the treatment field, 3 brands of blood-tonifying drugs are on the list, and 2 brands of cold drugs, intestinal drugs, cough and expectorant drugs, and cerebrovascular disease drugs are on the list
    .

    The sales of the 11 brands have increased to varying degrees.
    Jiangzhong Pharmaceutical's Jianweixiaoshi Tablets exceeded 1.
    4 billion yuan, and Taiji Group's Huoxiang Zhengqi Oral Liquid exceeded 1.
    2 billion yuan
    .
    In addition, the sales of Tiepi Fengdou Granules, an anti-cough, expectorant and anti-asthmatic drug of Zhejiang Emperor Pharmaceuticals, increased by 18.
    23%, thus successfully making the list of TOP20 proprietary Chinese medicine brands
    .

    Data source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.